Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
156.6 USD | +1.98% | +19.24% | -13.43% |
Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
Apr. 23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.43% | 16.05B | |
-2.63% | 103B | |
+1.66% | 95.28B | |
+1.46% | 22.15B | |
-15.25% | 21.02B | |
-8.58% | 18.15B | |
-41.01% | 16.73B | |
+4.58% | 13.68B | |
+35.44% | 12.17B | |
-23.62% | 8.24B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- BeiGene's Q4 2023 Net Loss Narrows as Revenue Increases; Misses Estimates